AnalystsKonstantinos N. AprilakisKonstantinos N. Aprilakis's Stock Forecasts
AnalystsKonstantinos N. Aprilakis
Sectors:
Analyst Ranking
Bottom 11%
#4584 out of 5143 analysts
Average Return
-10.93%
Win Rate
36%4 out of 11
Risk vs Reward
Poor
Good
Konstantinos N. Aprilakis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Blueprint Medicines CorpBPMC | +82.07% | $57.77 | $105.18 | 2020-03-17 - 2021-03-17 | Strong Buy |
Loxo Oncology IncLOXO | +47.51% | $159.08 | $234.66 | 2018-11-13 - 2019-02-15 | Buy |
Sutro Biopharma IncSTRO | +45.31% | $86.30 | $125.40 | 2019-09-05 - 2020-09-04 | Buy |
Loxo Oncology IncLOXO | +27.65% | $183.83 | $234.66 | 2018-06-04 - 2019-02-15 | Buy |
Konstantinos N. Aprilakis Analyst Color
Get additional color on Konstantinos N. Aprilakis's coverage of popular stocks
Konstantinos N. Aprilakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sutro Biopharma IncSTRO | 3 | Strong Buy | $250.00 | N/A | Initiates Coverage On | 5 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 5 years ago |
Mersana Therapeutics IncMRSN | 1 | Strong Buy | $825.00 | N/A | Initiates Coverage On | 5 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 5 years ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Adc Therapeutics SaADCT | 1 | Hold | $42.00 | N/A | Initiates Coverage On | 5 years ago |
Loxo Oncology IncLOXO | 2 | Buy | $215.00 | N/A | Maintains | 7 years ago |
Anaptysbio IncANAB | 1 | Buy | $153.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.